TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 20, No. 4 February 17, 2014
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
UPCOMING MEETINGS EVENTS
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 20, No. 4 February 17, 2014
(The next issue will be on March 3, 2014)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________None Submitted for this issue.
UPCOMING MEETINGS EVENTS
General info on upcoming meetings of interest:
http://tf7.org/meetings.htm
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
ISTH also maintains a list of upcoming meetings of
interest:
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
Ardillon L, Lefrancois A, Graveleau J, Fouassier M,
Ternisien C, Sigaud M, . . . Trossaert M (2014) Management of bleeding in
severe factor V deficiency with a factor V inhibitor. Vox Sang.
Backman S, Hiltunen L, Huoponen O, Vepsalainen K,
Riikonen P (2014) Inaccuracy in factor VIII measurement due to administration
of recombinant activated factor VII in vivo. Int J Lab Hematol.
Banov L, Pavanello M, Piattelli G, Disma N, Severino M,
Dufour C, Molinari AC (2014) Successful urgent neurosugery management with
rFVIIa mega doses in a child with haemophilia a and high titre inhibitor. Blood
Coagul Fibrinolysis.
Brophy GM, Candeloro CL, Robles JR, Brophy DF (2013)
Recombinant activated factor VII use in critically ill patients: clinical
outcomes and thromboembolic events. Ann Pharmacother 47:447-454.
Cesarman-Maus G, Braggio E, Lome-Maldonado C,
Morales-Leyte AL, Fonseca R (2014) Absence of tissue factor is characteristic
of lymphoid malignancies of both T- and B-cell origin. Thromb Res.
Dashty M, Motazacker MM, Levels J, Vries M, Mahmoudi M,
Peppelenbosch MP, Rezaee F (2014) Proteome of human plasma very low-density
lipoprotein and low-density lipoprotein exhibits a link with coagulation and
lipid metabolism. Thromb Haemost 111.
Davies GF, Berg A, Postnikoff SD, Wilson HL, Arnason TG,
Kusalik A, Harkness TA (2014) TFPI1 Mediates Resistance to Doxorubicin in
Breast Cancer Cells by Inducing a Hypoxic-Like Response. PLoS One 9:e84611.
Gatt A, Chowdary P (2014) Does Balanced Haemostasis
Equate to Normal Coagulation in Patients with Acute Liver Failure? Liver Int.
Geng Y, Verhamme IM, Sun MF, Bajaj SP, Emsley J, Gailani
D (2013) Analysis of the factor XI variant Arg184Gly suggests a structural
basis for factor IX binding to factor XIa. J Thromb Haemost 11:1374-1384.
Goel A, Nair SC, Viswabandya A, Masilamani VP, Rao SV,
George A, . . . Chandy G (2013) Preliminary experience with use of
recombinant activated factor VII to control postpartum hemorrhage in acute
fatty liver of pregnancy and other pregnancy-related liver disorders.
Indian J Gastroenterol 32:268-271.
Grottke O, van Ryn J, Spronk HM, Rossaint R (2014)
Prothrombin complex concentrates and a specific antidote to dabigatran are
effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver
trauma experimental model. Crit Care 18:R27.
Hammad MA, Abdel-Bakky MS, Walker LA, Ashfaq MK (2013)
Tissue factor antisense deoxyoligonucleotide prevents monocrotaline/LPS
hepatotoxicity in mice. J Appl Toxicol 33:774-783.
Harinstein LM, Morgan JW, Russo N (2013) Treatment of
dabigatran-associated bleeding: case report and review of the literature. J
Pharm Pract 26:264-269.
Hot A, Lavocat F, Maggi L, Annunziato F, Miossec P (2014)
A8.5 Comparison of the effects of TH17 and TH1 cells on endothelial cells and
synoviocytes. Ann Rheum Dis 73 Suppl 1:A78.
Ishibazawa A, Nagaoka T, Yokota H, Ono S, Yoshida A
(2013) Low shear stress up-regulation of proinflammatory gene expression in
human retinal microvascular endothelial cells. Exp Eye Res 116:308-311.
Jiang P, Xue D, Zhang Y, Ye L, Liu Y, Makale M, . . . Liu
C (2014) The extrinsic coagulation cascade and tissue factor pathway inhibitor
in macrophages: A potential therapeutic opportunity for atherosclerotic
thrombosis. Thromb Res.
Jin Y, Wang M, Wang Y, Yang X, Yang L, Xie Y, . . . Yu F
(2014) [Phenotype and genotype analysis for a consanguineous pedigree with
combined coagulation factor VII and X deficiency]. Zhonghua Yi Xue Yi Chuan Xue
Za Zhi 31:16-20.
Kato M, Atsumi T, Oku K, Amengual O, Nakagawa H, Fujieda
Y, . . .Koike T (2013) The involvement of CD36 in monocyte
activation by antiphospholipid antibodies. Lupus 22:761-771.
Ke K, Yuan J, Morrissey JH (2014) Tissue factor residues
that putatively interact with membrane phospholipids. PLoS One 9:e88675.
Keren-Politansky A, Breizman T, Brenner B, Sarig G,
Drugan A (2014) The coagulation profile of preterm delivery. Thromb Res.
Kothari H, Pendurthi UR, Rao LV (2013) Analysis of tissue
factor expression in various cell model systems: cryptic vs. active. J Thromb
Haemost 11:1353-1363.
Lipets E, Vlasova O, Urnova E, Margolin O, Soloveva A,
Ostapushchenko O, . . . Panteleev M (2014) Circulating
Contact-Pathway-Activating Microparticles Together with Factors IXa and XIa
Induce Spontaneous Clotting in Plasma of Hematology and Cardiologic Patients.
PLoS One 9:e87692.
Ljung R, Karim FA, Saxena K, Suzuki T, Arkhammar P,
Rosholm A, Giangrande P (2013) 40K glycoPEGylated, recombinant FVIIa: 3-month,
double-blind, randomized trial of safety, pharmacokinetics and preliminary
efficacy in hemophilia patients with inhibitors. J Thromb Haemost 11:1260-1268.
Ma D, Mizurini DM, Assumpcao TC, Li Y, Qi Y, Kotsyfakis
M, . . .Francischetti IM (2013) Desmolaris, a novel factor XIa
anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus)
inhibits inflammation and thrombosis in vivo. Blood 122:4094-4106.
Magnus N, Garnier D, Meehan B, McGraw S, Lee TH, Caron M,
. . . Rak J (2014) Tissue factor expression provokes escape from
tumor dormancy and leads to genomic alterations. Proc Natl Acad Sci U S A.
Majoor CJ, van de Pol MA, Kamphuisen PW, Meijers JC,
Molenkamp R, Wolthers KC, . . . van der Sluijs KF (2014) Evaluation of
coagulation activation after Rhinovirus infection in patients with asthma and
healthy control subjects: an observational study. Respir Res 15:14.
Martinez-Palacian A, Kanse SM, Weiskirchen R (2014)
Factor seven activating protease (FSAP): A novel protective factor in liver
fibrosis. Proteomics Clin Appl.
McCain S, Gull S, Ahmad J, Carey D (2014) Acquired
hemophilia A as a cause of acute upper gastrointestinal hemorrhage. BMJ Case
Rep 2014.
McElroy AK, Erickson BR, Flietstra TD, Rollin PE, Nichol
ST, Towner JS, Spiropoulou CF (2014) Ebola hemorrhagic fever: novel biomarker
correlates of clinical outcome. J Infect Dis.
Nielsen MH, Beck-Nielsen H, Andersen MN, Handberg A
(2014) A flow cytometric method for characterization of circulating
cell-derived microparticles in plasma. J Extracell Vesicles 3.
Pagano S, Virzi J, Satta N, Mannic T, Roux-Lombard P,
Mach F, . . .Vuilleumier N (2014) A9.11 Anti-apolipoprotein A1 autoantibodies
induce tissue factor activity and expression: a role in atherothrombosis. Ann
Rheum Dis 73 Suppl 1:A96.
Pham HP, Shaz BH (2013) Update on massive transfusion. Br
J Anaesth 111 Suppl 1:i71-82.
Priestley ES, De Lucca I, Zhou J, Zhou J, Saiah E,
Stanton R, . . .Wexler RR (2013) Discovery and gram-scale synthesis of
BMS-593214, a potent, selective FVIIa inhibitor. Bioorg Med Chem Lett
23:2432-2435.
Senchenkova EY, Russell J, Esmon CT, Granger DN (2014)
Roles of coagulation and fibrinolysis in angiotensin II enhanced microvascular
thrombosis. Microcirculation.
Sharma R, Dash SK, Chawla R, Kansal S, Agrawal DK, Dua H
(2013) Acquired hemophilia complicated by cardiorenal syndrome type 3. Indian J Crit Care Med 17:378-381.
Strickland DK, Au DT, Cunfer P, Muratoglu SC (2014)
Low-Density Lipoprotein Receptor-Related Protein-1: Role in the Regulation of
Vascular Integrity. Arterioscler Thromb Vasc Biol.
Tian Y, Ma S, Lin B, Kou J, Yu B (2013) Anti-thrombotic
activity of DT-13, a saponin isolated from the root tuber of Liriope muscari. Indian J Pharmacol 45:283-285.
Tseng JC, Chang LC, Jiang BY, Liu YC, Chen HJ, Yu CT, Hua
CC (2014) Elevated circulating levels of tissue factor-positive microvesicles
are associated with distant metastasis in lung cancer. J Cancer Res Clin Oncol
140:61-67.
Uruga H, Fujii T, Kurosaki A, Hanada S, Takaya H,
Miyamoto A, . . .Kishi K (2013) Pulmonary tumor thrombotic
microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med
52:1317-1323.
van Veen JJ, Maclean RM, Hampton KK, Hamer A, Makris M
(2014) Major surgery in severe haemophilia A with inhibitors using a recombinant
factor VIIa and activated prothrombin complex concentrate hybrid regimen.
Haemophilia.
Wang LL, Ma B, Qian D, Pang J, Yao YL (2013) [Correlation
between polymorphisms in the coagulation factor VII gene hypervariable region 4 site and the risk of coronary heart disease in
population with different ethnic backgrounds: a Meta-analysis]. Zhonghua Liu
Xing Bing Xue Za Zhi 34:1250-1254.
Waters EK, Genga RM, Thomson HA, Kurz JC, Schaub RG,
Scheiflinger F, McGinness KE (2013) Aptamer BAX 499 mediates inhibition of
tissue factor pathway inhibitor via interaction with multiple domains of the
protein. J Thromb Haemost 11:1137-1145.
Williams L, Deana A, Romero A, Molina A, Lunello P (2014)
High-level production of active human TFPI-2 Kunitz domain in plant. Protein
Expr Purif.
Yau JW, Liao P, Fredenburgh JC, Stafford A, Revenko AS,
Monia BP, Weitz JI (2014) Selective depletion of factor XI or factor XII with
antisense oligonucleotides attenuates catheter thrombosis in rabbits. Blood.
Yu G, Li H, Wang X, Wu T, Zhu J, Huang S, . . . Tang J
(2013) MicroRNA-19a targets tissue factor to inhibit colon cancer cells
migration and invasion. Mol Cell Biochem 380:239-247.
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
No comments:
Post a Comment